TL
Talis Biomedical Corporation
TLIS · OTC
$2.84 +0.00% (+$0.00)
Market Cap $5.18M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
50 /100
Fair P/B 0.07x
P/S 12.57x
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 66.48%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 15,050.20%
Op. margin 16,217.20%
FCF margin 13,040.30%
Quality
0 /100
Poor ROA 65.50%
Asset turnover 0.00x
ROIC 75.26%
Debt
96 /100
Low Current ratio 8.86x
Net debt/EBITDA 0.86x
Debt/Equity 0.28x
Stability
61 /100
Moderate EPS volatility 7.03%
Profitable years 0
Beta 1.32x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre TLIS
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Rebecca Markovich
Employees
99
Headquarters
Menlo Park